Sensitive content

This media may contain sensitive content.

Loading video...

Video Failed to Load

There was a problem loading this video. This could be due to a temporary network issue or the video might be unavailable.

Recently published #thoracic case report: Robotic-assisted thoracoscopic left secondary carinal resection and reconstruction with lung preservation for bronchial squamous cell carcinoma. Read now in #JTCVS Techniques:

AATS

16,322 subscribers

24,956 views • 2 months ago •via X (Twitter)

NSFW #thoracic #JTCVS

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

#TechniquesThursday: The first report of a robotic combined vascular ring division and mediastinal mass resection. See case details from researchers at Medical University of South Carolina (MUSC) in #JTCVS Techniques:

#TechniquesThursday: The first report of a robotic combined vascular ring division and mediastinal mass resection. See case details from researchers at Medical University of South Carolina (MUSC) in #JTCVS Techniques:

AATS

18,960 views • 1 year ago

✅ CT Reveal – Teaching Case CT pulmonary angiography – Lung and soft-tissue windows In this 22-year-old male with acute hemoptysis and hemoglobin drop, CT shows: ✔ Focal pulmonary hemorrhage involving the right middle and lower lobes. ✔ Expansion of the bronchus intermedius filled with an endobronchial soft-tissue lesion. ✔ Hemorrhage is downstream to the obstructed bronchus, explaining the lobar distribution seen on chest X-ray. 🎥 Lung and mediastinal window clips demonstrate the airway abnormality clearly. This confirms that the bleeding source is airway-related, not primary parenchymal or pulmonary arterial disease. ⸻ ✅ Bronchoscopy and Final Diagnosis Bronchoscopy revealed a large intrabronchial blood clot, and the patient was referred to thoracic surgery with the diagnosis of: 👉 Bronchial Dieulafoy disease. ⸻ ✅ What is Bronchial Dieulafoy Disease? Bronchial Dieulafoy disease is a rare vascular anomaly of the bronchial wall characterized by: •A dilated, tortuous submucosal artery that protrudes into the bronchial lumen. •Normal surrounding mucosa until rupture occurs. •Sudden, often massive hemoptysis, usually in young or middle-aged patients. •CT may show only indirect signs (endobronchial filling, clot, focal hemorrhage), while bronchoscopy and angiography are key for diagnosis and treatment. 📌 Biopsy is dangerous because it can trigger catastrophic bleeding. 📌 Management includes bronchial artery embolization or surgical resection when needed. ⸻ ✅ Teaching Points ✔ Always differentiate focal versus diffuse pulmonary hemorrhage. ✔ Focal, lobar hemorrhage should prompt careful evaluation of the airways. ✔ CT angiography must be reviewed in both lung and mediastinal windows, tracking the bronchi. ✔ Rare entities like Bronchial Dieulafoy disease can mimic tumors or mucus plugs on CT.

✅ CT Reveal – Teaching Case CT pulmonary angiography – Lung and soft-tissue windows In this 22-year-old male with acute hemoptysis and hemoglobin drop, CT shows: ✔ Focal pulmonary hemorrhage involving the right middle and lower lobes. ✔ Expansion of the bronchus intermedius filled with an endobronchial soft-tissue lesion. ✔ Hemorrhage is downstream to the obstructed bronchus, explaining the lobar distribution seen on chest X-ray. 🎥 Lung and mediastinal window clips demonstrate the airway abnormality clearly. This confirms that the bleeding source is airway-related, not primary parenchymal or pulmonary arterial disease. ⸻ ✅ Bronchoscopy and Final Diagnosis Bronchoscopy revealed a large intrabronchial blood clot, and the patient was referred to thoracic surgery with the diagnosis of: 👉 Bronchial Dieulafoy disease. ⸻ ✅ What is Bronchial Dieulafoy Disease? Bronchial Dieulafoy disease is a rare vascular anomaly of the bronchial wall characterized by: •A dilated, tortuous submucosal artery that protrudes into the bronchial lumen. •Normal surrounding mucosa until rupture occurs. •Sudden, often massive hemoptysis, usually in young or middle-aged patients. •CT may show only indirect signs (endobronchial filling, clot, focal hemorrhage), while bronchoscopy and angiography are key for diagnosis and treatment. 📌 Biopsy is dangerous because it can trigger catastrophic bleeding. 📌 Management includes bronchial artery embolization or surgical resection when needed. ⸻ ✅ Teaching Points ✔ Always differentiate focal versus diffuse pulmonary hemorrhage. ✔ Focal, lobar hemorrhage should prompt careful evaluation of the airways. ✔ CT angiography must be reviewed in both lung and mediastinal windows, tracking the bronchi. ✔ Rare entities like Bronchial Dieulafoy disease can mimic tumors or mucus plugs on CT.

Dr Khaled Ahmed Abuzeid

11,851 views • 6 months ago

Today, we've published the #StateofMed report - our annual report into the workplace experiences of doctors in the UK. The report highlights that after years of worsening job satisfaction and burnout, doctors are increasingly having to take their own steps to protect their wellbeing and patient care. This includes reducing their working hours. We're raising awareness of these findings with employers and healthcare bodies, urging them to act now to support doctors, while longer term solutions are in development. Read the report for more detail on doctors’ experiences and the solutions we’re proposing -

Today, we've published the #StateofMed report - our annual report into the workplace experiences of doctors in the UK. The report highlights that after years of worsening job satisfaction and burnout, doctors are increasingly having to take their own steps to protect their wellbeing and patient care. This includes reducing their working hours. We're raising awareness of these findings with employers and healthcare bodies, urging them to act now to support doctors, while longer term solutions are in development. Read the report for more detail on doctors’ experiences and the solutions we’re proposing -

GMC

64,325 views • 2 years ago

For six years, we have been told by officials on the Right and Left that there was NOTHING to see with Epstein’s death. Nobody entered the cell. He hung himself with paper sheets. It’s clear as day. But now, we find out that this whole time, investigators had FOOTAGE of an “orange shape” moving outside Epstein’s cell when no one else should have been in there, they NEVER found the noose, and the noose they did find wasn’t what killed him. This is the problem with the Epstein case: NO ONE trusts the government. You have to get that trust back or you don’t have a nation. RADICAL TRANSPARENCY. NOW.

For six years, we have been told by officials on the Right and Left that there was NOTHING to see with Epstein’s death. Nobody entered the cell. He hung himself with paper sheets. It’s clear as day. But now, we find out that this whole time, investigators had FOOTAGE of an “orange shape” moving outside Epstein’s cell when no one else should have been in there, they NEVER found the noose, and the noose they did find wasn’t what killed him. This is the problem with the Epstein case: NO ONE trusts the government. You have to get that trust back or you don’t have a nation. RADICAL TRANSPARENCY. NOW.

Glenn Beck

1,266,622 views • 5 months ago

Catheter-Directed PE Treatment: Does it Deliver? NEJM Clinician Editor-in-Chief Raja-Elie Abdulnour, MD (Raja-Elie Abdulnour), explains a trial recently published in NEJM that compared catheter-directed thrombolysis to anticoagulation alone for acute, intermediate-risk pulmonary embolism. Read the key results and comment from Michael E. Billington, MD: Visit to see What Matters Most This Week, including: 🫀 New ACC/AHA Guideline on Lipid Management and ASCVD Prevention 💊 Chronic Beta-Blocker Use in Low-Risk Patients after MI: Time to Re-Evaluate 🧠 Reducing the Risk of Recurrent Stroke in Patients with Left Ventricular Dysfunction 🎯 What's the Ideal LDL Target for Patients with Cardiovascular Disease?

Catheter-Directed PE Treatment: Does it Deliver? NEJM Clinician Editor-in-Chief Raja-Elie Abdulnour, MD (Raja-Elie Abdulnour), explains a trial recently published in NEJM that compared catheter-directed thrombolysis to anticoagulation alone for acute, intermediate-risk pulmonary embolism. Read the key results and comment from Michael E. Billington, MD: Visit to see What Matters Most This Week, including: 🫀 New ACC/AHA Guideline on Lipid Management and ASCVD Prevention 💊 Chronic Beta-Blocker Use in Low-Risk Patients after MI: Time to Re-Evaluate 🧠 Reducing the Risk of Recurrent Stroke in Patients with Left Ventricular Dysfunction 🎯 What's the Ideal LDL Target for Patients with Cardiovascular Disease?

NEJM

12,653 views • 3 months ago

Can Fenbendazole Cure Cancer? According to a case series published in an oncology journal, the answer could be a resounding yes. The case report highlights three cancer patients who were in pretty bad shape. But after taking fenbendazole, they all experienced a complete remission. What Is Fenbendazole, and How Does it Work? Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. Recently, anecdotal reports have praised fenbendazole as a potentially miraculous anti-cancer drug. It works by destabilizing microtubules, the structures that help cancer cells divide and grow. By disrupting this process, fenbendazole effectively halts cancer cell division and slows or stops tumor growth. Miraculous Recoveries After Taking Fenbendazole Case series #1 features a 63-year-old man with advanced kidney cancer (clear cell renal carcinoma) who experienced tumor recurrence and severe side effects from multiple cancer therapies, including surgery and two different medications. With no effective options left, he turned to fenbendazole (FBZ), taking 1 gram three times a week at a friend’s suggestion. Over the next 10 months, his tumors—including those in his pancreas and spine—showed near-complete resolution on imaging. Remarkably, he experienced no side effects from FBZ, and follow-up scans have shown no signs of recurrence. Case series #2 follows a 72-year-old man with metastatic urethral cancer that had spread to his lungs, lymph nodes, and brain. Despite undergoing multiple rounds of chemotherapy and radiation, one lymph node continued to grow, resisting all treatments. Seeking alternatives, he decided to try fenbendazole (FBZ), taking 1 gram three times a week, along with vitamin E, curcumin, and CBD oil, while postponing further conventional therapies. Over the next nine months, imaging revealed a dramatic response, with the lymph node shrinking significantly until it completely resolved. Remarkably, he reported no side effects during this period. Case series #3 focuses on a 63-year-old woman diagnosed with a large, invasive bladder tumor. Facing a challenging prognosis, she underwent chemotherapy while also taking fenbendazole (FBZ) at 1 gram three times a week. After completing six cycles of treatment, follow-up scans showed a complete resolution of the tumor, with only minimal thickening remaining in the bladder wall. Confident in her recovery, she chose to decline further surgery and remains disease-free under regular surveillance. The abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Reflecting on these remarkable case reports, Dr. John Campbell (John Campbell) urged drug regulators to “start looking at this as a matter of some urgency because people are dying from cancer now.” “So if something is safe and effective, surely it can be accredited for human use by our national authorizing agencies pretty quickly if they want to,” Dr. Campbell added with a hint of sarcasm. Of course, the key words here are “if they want to.” “Three patients, basically… cured of their cancers. Read the paper for yourself. That’s what they seem to be saying to me.”

Can Fenbendazole Cure Cancer? According to a case series published in an oncology journal, the answer could be a resounding yes. The case report highlights three cancer patients who were in pretty bad shape. But after taking fenbendazole, they all experienced a complete remission. What Is Fenbendazole, and How Does it Work? Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. Recently, anecdotal reports have praised fenbendazole as a potentially miraculous anti-cancer drug. It works by destabilizing microtubules, the structures that help cancer cells divide and grow. By disrupting this process, fenbendazole effectively halts cancer cell division and slows or stops tumor growth. Miraculous Recoveries After Taking Fenbendazole Case series #1 features a 63-year-old man with advanced kidney cancer (clear cell renal carcinoma) who experienced tumor recurrence and severe side effects from multiple cancer therapies, including surgery and two different medications. With no effective options left, he turned to fenbendazole (FBZ), taking 1 gram three times a week at a friend’s suggestion. Over the next 10 months, his tumors—including those in his pancreas and spine—showed near-complete resolution on imaging. Remarkably, he experienced no side effects from FBZ, and follow-up scans have shown no signs of recurrence. Case series #2 follows a 72-year-old man with metastatic urethral cancer that had spread to his lungs, lymph nodes, and brain. Despite undergoing multiple rounds of chemotherapy and radiation, one lymph node continued to grow, resisting all treatments. Seeking alternatives, he decided to try fenbendazole (FBZ), taking 1 gram three times a week, along with vitamin E, curcumin, and CBD oil, while postponing further conventional therapies. Over the next nine months, imaging revealed a dramatic response, with the lymph node shrinking significantly until it completely resolved. Remarkably, he reported no side effects during this period. Case series #3 focuses on a 63-year-old woman diagnosed with a large, invasive bladder tumor. Facing a challenging prognosis, she underwent chemotherapy while also taking fenbendazole (FBZ) at 1 gram three times a week. After completing six cycles of treatment, follow-up scans showed a complete resolution of the tumor, with only minimal thickening remaining in the bladder wall. Confident in her recovery, she chose to decline further surgery and remains disease-free under regular surveillance. The abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Reflecting on these remarkable case reports, Dr. John Campbell (John Campbell) urged drug regulators to “start looking at this as a matter of some urgency because people are dying from cancer now.” “So if something is safe and effective, surely it can be accredited for human use by our national authorizing agencies pretty quickly if they want to,” Dr. Campbell added with a hint of sarcasm. Of course, the key words here are “if they want to.” “Three patients, basically… cured of their cancers. Read the paper for yourself. That’s what they seem to be saying to me.”

The Vigilant Fox 🦊

405,353 views • 1 year ago

Can Fenbendazole Cure Cancer? According to a case series published in an oncology journal, the answer could be a resounding yes. The case report highlights three cancer patients who were in pretty bad shape. But after taking fenbendazole, they all experienced a complete remission. What Is Fenbendazole, and How Does it Work? Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. Recently, anecdotal reports have praised fenbendazole as a potentially miraculous anti-cancer drug. It works by destabilizing microtubules, the structures that help cancer cells divide and grow. By disrupting this process, fenbendazole effectively halts cancer cell division and slows or stops tumor growth. Miraculous Recoveries After Taking Fenbendazole Case series #1 features a 63-year-old man with advanced kidney cancer (clear cell renal carcinoma) who experienced tumor recurrence and severe side effects from multiple cancer therapies, including surgery and two different medications. With no effective options left, he turned to fenbendazole (FBZ), taking 1 gram three times a week at a friend’s suggestion. Over the next 10 months, his tumors—including those in his pancreas and spine—showed near-complete resolution on imaging. Remarkably, he experienced no side effects from FBZ, and follow-up scans have shown no signs of recurrence. Case series #2 follows a 72-year-old man with metastatic urethral cancer that had spread to his lungs, lymph nodes, and brain. Despite undergoing multiple rounds of chemotherapy and radiation, one lymph node continued to grow, resisting all treatments. Seeking alternatives, he decided to try fenbendazole (FBZ), taking 1 gram three times a week, along with vitamin E, curcumin, and CBD oil, while postponing further conventional therapies. Over the next nine months, imaging revealed a dramatic response, with the lymph node shrinking significantly until it completely resolved. Remarkably, he reported no side effects during this period. Case series #3 focuses on a 63-year-old woman diagnosed with a large, invasive bladder tumor. Facing a challenging prognosis, she underwent chemotherapy while also taking fenbendazole (FBZ) at 1 gram three times a week. After completing six cycles of treatment, follow-up scans showed a complete resolution of the tumor, with only minimal thickening remaining in the bladder wall. Confident in her recovery, she chose to decline further surgery and remains disease-free under regular surveillance. The abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Reflecting on these remarkable case reports, Dr. John Campbell (John Campbell) urged drug regulators to “start looking at this as a matter of some urgency because people are dying from cancer now.” “So if something is safe and effective, surely it can be accredited for human use by our national authorizing agencies pretty quickly if they want to,” Dr. Campbell added with a hint of sarcasm. Of course, the key words here are “if they want to.” “Three patients, basically… cured of their cancers. Read the paper for yourself. That’s what they seem to be saying to me.”

Can Fenbendazole Cure Cancer? According to a case series published in an oncology journal, the answer could be a resounding yes. The case report highlights three cancer patients who were in pretty bad shape. But after taking fenbendazole, they all experienced a complete remission. What Is Fenbendazole, and How Does it Work? Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. Recently, anecdotal reports have praised fenbendazole as a potentially miraculous anti-cancer drug. It works by destabilizing microtubules, the structures that help cancer cells divide and grow. By disrupting this process, fenbendazole effectively halts cancer cell division and slows or stops tumor growth. Miraculous Recoveries After Taking Fenbendazole Case series #1 features a 63-year-old man with advanced kidney cancer (clear cell renal carcinoma) who experienced tumor recurrence and severe side effects from multiple cancer therapies, including surgery and two different medications. With no effective options left, he turned to fenbendazole (FBZ), taking 1 gram three times a week at a friend’s suggestion. Over the next 10 months, his tumors—including those in his pancreas and spine—showed near-complete resolution on imaging. Remarkably, he experienced no side effects from FBZ, and follow-up scans have shown no signs of recurrence. Case series #2 follows a 72-year-old man with metastatic urethral cancer that had spread to his lungs, lymph nodes, and brain. Despite undergoing multiple rounds of chemotherapy and radiation, one lymph node continued to grow, resisting all treatments. Seeking alternatives, he decided to try fenbendazole (FBZ), taking 1 gram three times a week, along with vitamin E, curcumin, and CBD oil, while postponing further conventional therapies. Over the next nine months, imaging revealed a dramatic response, with the lymph node shrinking significantly until it completely resolved. Remarkably, he reported no side effects during this period. Case series #3 focuses on a 63-year-old woman diagnosed with a large, invasive bladder tumor. Facing a challenging prognosis, she underwent chemotherapy while also taking fenbendazole (FBZ) at 1 gram three times a week. After completing six cycles of treatment, follow-up scans showed a complete resolution of the tumor, with only minimal thickening remaining in the bladder wall. Confident in her recovery, she chose to decline further surgery and remains disease-free under regular surveillance. The abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Reflecting on these remarkable case reports, Dr. John Campbell (John Campbell) urged drug regulators to “start looking at this as a matter of some urgency because people are dying from cancer now.” “So if something is safe and effective, surely it can be accredited for human use by our national authorizing agencies pretty quickly if they want to,” Dr. Campbell added with a hint of sarcasm. Of course, the key words here are “if they want to.” “Three patients, basically… cured of their cancers. Read the paper for yourself. That’s what they seem to be saying to me.”

The Vigilant Fox 🦊

1,477,356 views • 1 year ago

🚨 JUST NOW: New Jersey Democrats have made a stunning decision to nominate an ISLAMIC TERRORIST-linked candidate for US Congress, Adam Hamawy (D) WINS the primary... ...he was associated with Omar Abdel-Rahman, convicted of TERRORISM and seditious CONSPIRACY in 1996 🤯 "Prosecutors said it was Rahman, who led the jihadi terror cell of Islamic militants, who in November of 1990, assassinated extremist rabbi, Maya Kahane, as he spoke at a Manhattan hotel." "Then three years later, in 1993, the sheikh and his cell bombed the World Trade Center to try and bring it down. But that attack killed six people, injured more than 1,000." "And two years later, the sheikh and his terror cell plotted to blow up New York City landmarks. Rahman was sentenced to life in prison and died behind bars nine years ago. Turns out that Hamawy testified at the blind sheikh's terrorist trial as a defense witness, according to published report transcripts." The Democrats are becoming the party of ISLAMIC TERROR. He is a national security risk.

🚨 JUST NOW: New Jersey Democrats have made a stunning decision to nominate an ISLAMIC TERRORIST-linked candidate for US Congress, Adam Hamawy (D) WINS the primary... ...he was associated with Omar Abdel-Rahman, convicted of TERRORISM and seditious CONSPIRACY in 1996 🤯 "Prosecutors said it was Rahman, who led the jihadi terror cell of Islamic militants, who in November of 1990, assassinated extremist rabbi, Maya Kahane, as he spoke at a Manhattan hotel." "Then three years later, in 1993, the sheikh and his cell bombed the World Trade Center to try and bring it down. But that attack killed six people, injured more than 1,000." "And two years later, the sheikh and his terror cell plotted to blow up New York City landmarks. Rahman was sentenced to life in prison and died behind bars nine years ago. Turns out that Hamawy testified at the blind sheikh's terrorist trial as a defense witness, according to published report transcripts." The Democrats are becoming the party of ISLAMIC TERROR. He is a national security risk.

Eric Daugherty

253,544 views • 1 month ago

BLUEPRINT EXPOSED: Bill Gates & WHO Make Shocking Admission on Digital ID | Daily Pulse Refuse the shot? They’ll freeze your bank account. Say the wrong thing? You're locked out of society. They want every child tracked from birth—with your access to money, movement, and speech tied to a digital ID. An extremely disturbing bulletin was published recently and barely anyone is talking about it. In a document published in the October Bulletin of the World Health Organization, funded by the Gates Foundation, the WHO is proposing a globally interoperable digital identity infrastructure that permanently tracks every individual’s vaccination status from birth. The proposed system will track things like socioeconomic data such as household income, ethnicity, and religion. It deploys artificial intelligence for identifying and targeting the unreached and combating misinformation, and enables governments to use vaccination records as prerequisites for education, travel, and other services. We’ve warned about this being the agenda for many years, and now it’s on paper—and it’s happening now. ZeeeMediaOfficial's special report goes through everything you need to know. 🧵 THREAD

BLUEPRINT EXPOSED: Bill Gates & WHO Make Shocking Admission on Digital ID | Daily Pulse Refuse the shot? They’ll freeze your bank account. Say the wrong thing? You're locked out of society. They want every child tracked from birth—with your access to money, movement, and speech tied to a digital ID. An extremely disturbing bulletin was published recently and barely anyone is talking about it. In a document published in the October Bulletin of the World Health Organization, funded by the Gates Foundation, the WHO is proposing a globally interoperable digital identity infrastructure that permanently tracks every individual’s vaccination status from birth. The proposed system will track things like socioeconomic data such as household income, ethnicity, and religion. It deploys artificial intelligence for identifying and targeting the unreached and combating misinformation, and enables governments to use vaccination records as prerequisites for education, travel, and other services. We’ve warned about this being the agenda for many years, and now it’s on paper—and it’s happening now. ZeeeMediaOfficial's special report goes through everything you need to know. 🧵 THREAD

The Vigilant Fox 🦊

134,276 views • 7 months ago

Nothing can be more shameful for Punjab than a Chief Minister facing allegations of sacrilegious conduct and then allegedly using the power of his office to cover it up. After the Akal Takht Sahib’s order on 15 June, senior Punjab Police officers were sent to secure a favourable forensic report with ₹10 lakh deal with a forensic lab in Gurugram. The seriousness of the matter is evident from the FIR registered by Haryana Police against Punjab Govt officials and others for coercing a cyber expert into fabricating a forensic report in favour of Punjab CM. Mann Sahab has lost all moral authority to remain in office. He must step down. This is now a litmus test for Punjab Police. The recently enacted Beadbi law cannot become a tool only for ordinary citizens while the Chief Minister remains above scrutiny. The very first case under the law should be registered against Bhagwant Mann. Most importantly, Punjab is now facing a grave constitutional crisis. A sitting Chief Minister stands accused of misusing police and state machinery to shield himself from accountability. This is a fit case for Bhagwant Mann’s removal from office.

Nothing can be more shameful for Punjab than a Chief Minister facing allegations of sacrilegious conduct and then allegedly using the power of his office to cover it up. After the Akal Takht Sahib’s order on 15 June, senior Punjab Police officers were sent to secure a favourable forensic report with ₹10 lakh deal with a forensic lab in Gurugram. The seriousness of the matter is evident from the FIR registered by Haryana Police against Punjab Govt officials and others for coercing a cyber expert into fabricating a forensic report in favour of Punjab CM. Mann Sahab has lost all moral authority to remain in office. He must step down. This is now a litmus test for Punjab Police. The recently enacted Beadbi law cannot become a tool only for ordinary citizens while the Chief Minister remains above scrutiny. The very first case under the law should be registered against Bhagwant Mann. Most importantly, Punjab is now facing a grave constitutional crisis. A sitting Chief Minister stands accused of misusing police and state machinery to shield himself from accountability. This is a fit case for Bhagwant Mann’s removal from office.

Manjinder Singh Sirsa

31,008 views • 1 month ago

KAREN READ TRIAL REVIEW #5: “During a federal proffer, #BrianHiggins admits that he had been served with a preservation order, and the Commonwealth told him he could destroy his phone despite the order. He then drives to a military base on Cape Cod, opens his phone, breaks the SIM card, and throws the phone away. He says that he discussed destroying his phone with #BrianAlbert. Brian Albert also destroyed his phone. And Brian Albert said that he had received some texts that concerned him as an explanation. And after that, Brian Higgins changes his phone number and his cell carrier. In short, he was present that night, he had a motive, and there is plenty of consciousness of guilt coverup evidence with regard to Mr. Higgins.” — Federal Touhy evidence provided by the Federal investigation. —————— The Federal investigation was “thorough”, to the tune of producing over 3k+ pages of evidence inculpating third party culprits, or exculpatory evidence for #KarenRead. Some people—without any evidence—claim the federal investigation closed and cleared the very people who it quite literally inculpated through its evidence thus far. This, of course, ignores the fact that the abstention doctrine precludes the federal government from intruding in ongoing state matters, which unlike the #SandraBirchmore case, for instance, applies to this—the Karen Read case pending resolution. #FreeKarenRead #KarenReadTrial #JusticeForJohnOKeefe

KAREN READ TRIAL REVIEW #5: “During a federal proffer, #BrianHiggins admits that he had been served with a preservation order, and the Commonwealth told him he could destroy his phone despite the order. He then drives to a military base on Cape Cod, opens his phone, breaks the SIM card, and throws the phone away. He says that he discussed destroying his phone with #BrianAlbert. Brian Albert also destroyed his phone. And Brian Albert said that he had received some texts that concerned him as an explanation. And after that, Brian Higgins changes his phone number and his cell carrier. In short, he was present that night, he had a motive, and there is plenty of consciousness of guilt coverup evidence with regard to Mr. Higgins.” — Federal Touhy evidence provided by the Federal investigation. —————— The Federal investigation was “thorough”, to the tune of producing over 3k+ pages of evidence inculpating third party culprits, or exculpatory evidence for #KarenRead. Some people—without any evidence—claim the federal investigation closed and cleared the very people who it quite literally inculpated through its evidence thus far. This, of course, ignores the fact that the abstention doctrine precludes the federal government from intruding in ongoing state matters, which unlike the #SandraBirchmore case, for instance, applies to this—the Karen Read case pending resolution. #FreeKarenRead #KarenReadTrial #JusticeForJohnOKeefe

Olivia

181,177 views • 1 year ago

Ivermectin is the wonder drug that keeps on giving: It’s now showing promise against the New World screwworm in both cattle AND HUMANS. Multiple field trials and case reports have found that ivermectin can kill the larvae responsible for these devastating infestations. In one human case series, physicians treated six patients suffering from severe oral infestations. After receiving ivermectin, the remaining larvae died and became significantly easier to remove. All six patients recovered without major complications. Another report described two patients with New World screwworm infestations around the eye socket. The larvae had burrowed deep into surrounding tissue, creating a serious risk of progressive tissue destruction. After treatment with ivermectin and wound debridement, the larvae died, could be removed more effectively, and further damage was brought under control. The findings mirror what veterinarians have observed for years in livestock, where ivermectin has been used to combat parasitic infestations that threaten animal health and agricultural production. Once again, ivermectin appears to be doing exactly what it was designed to do: kill parasites. “Horse paste” wins again. For the full details, read Nicolas Hulscher, MPH's report:

Ivermectin is the wonder drug that keeps on giving: It’s now showing promise against the New World screwworm in both cattle AND HUMANS. Multiple field trials and case reports have found that ivermectin can kill the larvae responsible for these devastating infestations. In one human case series, physicians treated six patients suffering from severe oral infestations. After receiving ivermectin, the remaining larvae died and became significantly easier to remove. All six patients recovered without major complications. Another report described two patients with New World screwworm infestations around the eye socket. The larvae had burrowed deep into surrounding tissue, creating a serious risk of progressive tissue destruction. After treatment with ivermectin and wound debridement, the larvae died, could be removed more effectively, and further damage was brought under control. The findings mirror what veterinarians have observed for years in livestock, where ivermectin has been used to combat parasitic infestations that threaten animal health and agricultural production. Once again, ivermectin appears to be doing exactly what it was designed to do: kill parasites. “Horse paste” wins again. For the full details, read Nicolas Hulscher, MPH's report:

The Vigilant Fox 🦊

55,227 views • 1 month ago

I am humbled to share a significant milestone in pancreatic surgery: I recently performed the first-ever da Vinci single-port robotic distal pancreatectomy and splenectomy without an additional incision for pancreatic cancer in the United States, approved by both the Institutional Review Board and IDE from the FDA through a 2cm incision inside the belly button leaving no additional scar. This pioneering procedure not only achieved negative margins but also allowed for the thorough harvesting of all local lymphatics, a critical factor in ensuring comprehensive cancer treatment. I am grateful to report that the patient is doing exceptionally well, and it was a privilege to see him in the clinic several days post-operation. The images included illustrate the operating room moments and a snapshot of our follow-up clinic visit with my remarkable ARNP Dana Manzi and myself. This journey underscores the importance of innovation in surgical techniques and the profound impact they can have on patient outcomes. Thank you to everyone who has supported and believed in this work. THANK YOU INTUITIVE SURGICAL FOR DEVELOPING SUCH AN INCREDIBLE SURGICAL TECHNOLOGY. #pancreaticcancer #DaVinciSinglePortRobot #women #roboticsurgery #innovations #surgery AdventHealth AdventHealthWFL AdventHealthCFL BayCare HCA Healthcare Moffitt Cancer Center Tampa General Hospital USF Health Medicine USF Health UCF Health FSU Seminoles FLORIDA UMiami Health System Miller Medicine FIU Intuitive Medtronic Johnson & Johnson Olympus Boston Scientific NVIDIA Women in Surgery WomenSurgeons SAGES is in Vegas in 2027! AHPBA E-AHPBA IHPBA American College of Surgeons Journal of the American College of Surgeons (JACS) Florida Lancer SSAT Society of Robotic Surgery | SRS Society of Laparoscopic & Robotic Surgery (SLS) Pancreatic Cancer Action Pancreatic Cancer North America

I am humbled to share a significant milestone in pancreatic surgery: I recently performed the first-ever da Vinci single-port robotic distal pancreatectomy and splenectomy without an additional incision for pancreatic cancer in the United States, approved by both the Institutional Review Board and IDE from the FDA through a 2cm incision inside the belly button leaving no additional scar. This pioneering procedure not only achieved negative margins but also allowed for the thorough harvesting of all local lymphatics, a critical factor in ensuring comprehensive cancer treatment. I am grateful to report that the patient is doing exceptionally well, and it was a privilege to see him in the clinic several days post-operation. The images included illustrate the operating room moments and a snapshot of our follow-up clinic visit with my remarkable ARNP Dana Manzi and myself. This journey underscores the importance of innovation in surgical techniques and the profound impact they can have on patient outcomes. Thank you to everyone who has supported and believed in this work. THANK YOU INTUITIVE SURGICAL FOR DEVELOPING SUCH AN INCREDIBLE SURGICAL TECHNOLOGY. #pancreaticcancer #DaVinciSinglePortRobot #women #roboticsurgery #innovations #surgery AdventHealth AdventHealthWFL AdventHealthCFL BayCare HCA Healthcare Moffitt Cancer Center Tampa General Hospital USF Health Medicine USF Health UCF Health FSU Seminoles FLORIDA UMiami Health System Miller Medicine FIU Intuitive Medtronic Johnson & Johnson Olympus Boston Scientific NVIDIA Women in Surgery WomenSurgeons SAGES is in Vegas in 2027! AHPBA E-AHPBA IHPBA American College of Surgeons Journal of the American College of Surgeons (JACS) Florida Lancer SSAT Society of Robotic Surgery | SRS Society of Laparoscopic & Robotic Surgery (SLS) Pancreatic Cancer Action Pancreatic Cancer North America

Sharona B. Ross

27,468 views • 1 month ago

December 16, 2016. Obama does an hour long interview with NPR. The entire interview is stunning for a few reasons. 1. Almost everything Obama says is in direct contradiction to the intelligence report on the election that he had just recently received. The majority of this interview was spent discussing Russia's election interference to help Trump. We now know that Obama had just received a report informing him that did not happen. 2. It was extremely obvious throughout the entire interview that Obama was lying and that he knew the significance of what he was doing. 3. Obama finished the interview, left and returned to talk about a new "Intelligence Assessment" that would be dropping before Trump's inauguration. He was priming the media to be on the look out for the bogus report he had just asked for. It's impossible to overstate the magnitude of what Obama was doing during this interview. And of course he turned to NPR to help him do his dirty work.

December 16, 2016. Obama does an hour long interview with NPR. The entire interview is stunning for a few reasons. 1. Almost everything Obama says is in direct contradiction to the intelligence report on the election that he had just recently received. The majority of this interview was spent discussing Russia's election interference to help Trump. We now know that Obama had just received a report informing him that did not happen. 2. It was extremely obvious throughout the entire interview that Obama was lying and that he knew the significance of what he was doing. 3. Obama finished the interview, left and returned to talk about a new "Intelligence Assessment" that would be dropping before Trump's inauguration. He was priming the media to be on the look out for the bogus report he had just asked for. It's impossible to overstate the magnitude of what Obama was doing during this interview. And of course he turned to NPR to help him do his dirty work.

MAZE

1,100,844 views • 1 year ago

#ArtnetNews: In the first half of 2025, fine-art auction sales during the first half of 2025 totaled $4.72 billion, down 8.8 percent from the same period a year ago and down 40.9 percent from 2022’s first half, according to the Artnet Price Database. Major galleries shut their doors, while others scaled back. The downturn is structural: an oversaturated market of galleries, fairs, and advisors, paired with inflated primary prices and weak secondary demand for countless living artists, has left both speculators and collectors on the sidelines. The result is a state of contraction, the feeling of malaise. Yet younger dealers and leaner models are emerging. As one dealer put it, “Dinosaurs were wiped out. That was the rise of the mammals.” Artnet's Katya Kazakina takes a deep dive in our latest Intelligence Report. Read more:

#ArtnetNews: In the first half of 2025, fine-art auction sales during the first half of 2025 totaled $4.72 billion, down 8.8 percent from the same period a year ago and down 40.9 percent from 2022’s first half, according to the Artnet Price Database. Major galleries shut their doors, while others scaled back. The downturn is structural: an oversaturated market of galleries, fairs, and advisors, paired with inflated primary prices and weak secondary demand for countless living artists, has left both speculators and collectors on the sidelines. The result is a state of contraction, the feeling of malaise. Yet younger dealers and leaner models are emerging. As one dealer put it, “Dinosaurs were wiped out. That was the rise of the mammals.” Artnet's Katya Kazakina takes a deep dive in our latest Intelligence Report. Read more:

Artnet

13,204 views • 10 months ago

READ WITH CAUTION - EXPOSING THE LEFT AND THEIR WARPED NARRATIVES REGARDING KARMELO ANTHONY - SENSITIVE INFO Karmelo defenders are already trying to spin my lawsuit against Charleston White as a “publicity stunt,” claiming I’m just seeking attention. My reporting on this case has gained international attention. I placed a microscope over the Anthony family and Dominique Alexander, backing everything with documents and evidence. They hate me for it. I am eight months pregnant. In my final month of pregnancy, I would rather focus on bringing another precious baby into the world and preparing for motherhood. The last thing I wanted was to be harassed, doxxed, and smeared with accusations of meth use and prostitution, all because they didn’t like my reporting, which affected their ability to raise funds for Karmelo Anthony. I recently discovered the new narrative they are spinning. Drew Anthony met with Charleston White just before Charleston decided to go public and say all the sick things he said about me and the Metcalf family. Drew Anthony told Charleston that there was a pool party where all the teens were making fun of Karmelo’s “large genitalia” and that he was bullied for this, which is why he decided to murder Austin Metcalf. Only a sick, twisted mind would come up with a narrative like this. Only a liberal’s mind would jump to thinking about a minor’s genitalia to create a fake “self-defense” case. Tiffney Billions (the activist in contact with Drew Anthony, who has spun multiple lies about the Metcalfs and the twins) is also claiming there is a police report for an incident between a cheerleader and the Metcalf brothers. There is no such report. This is what they do: they are preparing for a race war next summer, fabricating a narrative to rile up their base and instill fear in the jury. This is why I will not stop working to dispel their lies. I have been lied about by the left for years. A lawsuit is long overdue. Words have consequences, and we must work to protect the Metcalfs and ensure the jury is protected at all costs.

READ WITH CAUTION - EXPOSING THE LEFT AND THEIR WARPED NARRATIVES REGARDING KARMELO ANTHONY - SENSITIVE INFO Karmelo defenders are already trying to spin my lawsuit against Charleston White as a “publicity stunt,” claiming I’m just seeking attention. My reporting on this case has gained international attention. I placed a microscope over the Anthony family and Dominique Alexander, backing everything with documents and evidence. They hate me for it. I am eight months pregnant. In my final month of pregnancy, I would rather focus on bringing another precious baby into the world and preparing for motherhood. The last thing I wanted was to be harassed, doxxed, and smeared with accusations of meth use and prostitution, all because they didn’t like my reporting, which affected their ability to raise funds for Karmelo Anthony. I recently discovered the new narrative they are spinning. Drew Anthony met with Charleston White just before Charleston decided to go public and say all the sick things he said about me and the Metcalf family. Drew Anthony told Charleston that there was a pool party where all the teens were making fun of Karmelo’s “large genitalia” and that he was bullied for this, which is why he decided to murder Austin Metcalf. Only a sick, twisted mind would come up with a narrative like this. Only a liberal’s mind would jump to thinking about a minor’s genitalia to create a fake “self-defense” case. Tiffney Billions (the activist in contact with Drew Anthony, who has spun multiple lies about the Metcalfs and the twins) is also claiming there is a police report for an incident between a cheerleader and the Metcalf brothers. There is no such report. This is what they do: they are preparing for a race war next summer, fabricating a narrative to rile up their base and instill fear in the jury. This is why I will not stop working to dispel their lies. I have been lied about by the left for years. A lawsuit is long overdue. Words have consequences, and we must work to protect the Metcalfs and ensure the jury is protected at all costs.

Sarah Fields

54,060 views • 1 year ago

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?

Camus

615,291 views • 1 year ago

MMA fighter Ben Askren says he refuses to feel sorry for himself after undergoing a double lung transplant. The update comes after Aksren revealed he "died 4 times" after a severe case of pneumonia that has left him in the hospital for over a month. "I never smoked one cigarette, never smoked any weed, never anything. Why did my lungs get stolen from me, right?" "[I thought], why couldn't this be happening to someone who smokes habitually? Then I realized, it happened, it's over, done with." "I could be bitter and angry. I could whine, cry. This ain't going to help anybody. I am where I am now, and I'm going to move forward the best that I can." Inspirational. Video: Funky 🇺🇸🇺🇸🇺🇸

MMA fighter Ben Askren says he refuses to feel sorry for himself after undergoing a double lung transplant. The update comes after Aksren revealed he "died 4 times" after a severe case of pneumonia that has left him in the hospital for over a month. "I never smoked one cigarette, never smoked any weed, never anything. Why did my lungs get stolen from me, right?" "[I thought], why couldn't this be happening to someone who smokes habitually? Then I realized, it happened, it's over, done with." "I could be bitter and angry. I could whine, cry. This ain't going to help anybody. I am where I am now, and I'm going to move forward the best that I can." Inspirational. Video: Funky 🇺🇸🇺🇸🇺🇸

Collin Rugg

156,620 views • 1 year ago